Metal organic frameworks modified mesoporous silica nanoparticles (MSN): A nano-composite system to inhibit uncontrolled chemotherapeutic drug delivery from Bare-MSN

Kamaly, 2016, Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release, Chem. Rev., 116, 2602, 10.1021/acs.chemrev.5b00346

Madden, 1999, Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity, Nat. Biotechnol., 17, 775, 10.1038/11710

Zhang, 2016, Mechanical force-triggered drug delivery, Chem. Rev., 116, 12536, 10.1021/acs.chemrev.6b00369

Uhrich, 1999, Polymeric systems for controlled drug release, Chem. Rev., 99, 3181, 10.1021/cr940351u

Brus, 2017, Exploring the molecular-level architecture of the active compounds in liquisolid drug delivery systems based on mesoporous silica particles: old tricks for new challenges, Mol. Pharm., 14, 2070, 10.1021/acs.molpharmaceut.7b00167

Huang, 2017, Phosphonated pillar[5]arene-valved mesoporous silica drug delivery systems, ACS Appl. Mater. Interfaces, 9, 19638, 10.1021/acsami.7b04015

Mekuria, 2016, IL-6 antibody and RGD peptide conjugated poly(amidoamine) dendrimer for targeted drug delivery of HeLa cells, J. Phys. Chem. B, 120, 123, 10.1021/acs.jpcb.5b11125

Otla, 2017, Biomimetic lipid-based nanosystems for enhanced dermal delivery of drugs and bioactive agents, ACS Biomater. Sci. Eng., 3, 1262, 10.1021/acsbiomaterials.6b00681

Chen, 2016, Intelligent drug delivery system based on mesoporous silica nanoparticles coated with an ultra-pH-sensitive gatekeeper and poly(ethylene glycol), ACS Macro Lett., 5, 55, 10.1021/acsmacrolett.5b00765

Liong, 2008, Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery, ACS Nano, 2, 889, 10.1021/nn800072t

Lee, 2011, Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications, Acc. Chem. Res., 44, 893, 10.1021/ar2000259

Slowing, 2007, Mesoporous silica nanoparticles for drug delivery and biosensing applications, Adv. Funct. Mater., 17, 1225, 10.1002/adfm.200601191

Liu, 2011, Fluorescence turn-on chemodosimeter-functionalized mesoporous silica nanoparticles and their application in cell imaging, J. Mater. Chem., 21, 7175, 10.1039/c1jm10803d

Salinas, 2013, A tissue engineering approach based on the use of bioceramics for bone repair, Biomater. Sci., 1, 40, 10.1039/C2BM00071G

Ehlert, 2013, Mesoporous silica films as a novel biomaterial: applications in the middle ear, Chem. Soc. Rev., 42, 3847, 10.1039/c3cs35359a

Vitale-Brovarone, 2009, Glass-ceramic scaffolds containing silica mesophases for bone grafting and drug delivery, J. Mater. Sci. Mater. Med., 20, 809, 10.1007/s10856-008-3635-7

Wang, 2016, Synthesis, properties, and applications of hollow micro-/nanostructures, Chem. Rev., 116, 10983, 10.1021/acs.chemrev.5b00731

Chen, 2016, Nanochemistry and nanomedicine for nanoparticle-based diagnostics and therapy, Chem. Rev., 116, 2826, 10.1021/acs.chemrev.5b00148

Vallet-Regý´, 2008, Bone-regenerative bioceramic implants with drug and protein controlled delivery capability, Prog. Solid State Chem., 36, 163, 10.1016/j.progsolidstchem.2007.10.002

Chang, 2007, Vitro cytotoxicitiy of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line, Environ. Sci. Technol., 41, 2064, 10.1021/es062347t

Ruehle, 2017, A pathogen-specific cargo delivery platform based on mesoporous silica nanoparticles, J. Am. Chem. Soc., 139, 6663, 10.1021/jacs.7b01278

Zhu, 2010, Rattle-Type Fe3O4@ SiO2 hollow mesoporous spheres as carriers for drug delivery, Small, 6, 471, 10.1002/smll.200901403

Meng, 2010, Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves, J. Am. Chem. Soc., 132, 12690, 10.1021/ja104501a

Chen, 2011, Multifunctional magnetically removable nanogated lids of Fe3O4 capped mesoporous silica nanoparticles for intracellular controlled release and MR imaging, J. Mater. Chem., 21, 2535, 10.1039/c0jm02590a

Chen, 2011, Double mesoporous silica shelled spherical/ellipsoidal nanostructures: synthesis and hydrophilic/hydrophobic anticancer drug delivery, J. Mater. Chem., 21, 5290, 10.1039/c0jm04024j

Rowsell, 2005, Strategies for hydrogen storage in metal-organic frameworks, Angew. Chem. Int. Ed., 4, 4670, 10.1002/anie.200462786

Dinca, 2008, Hydrogen storage in microporous metal-organic frameworks with exposed metal sites, Angew. Chem. Int. Ed., 47, 6766, 10.1002/anie.200801163

Chen, 2007, Selective gas sorption within a dynamic metal-organic framework, Inorg. Chem., 46, 8705, 10.1021/ic7013573

Chen, 2010, Metal organic frameworks with functional pores for recognition of small molecules, Acc. Chem. Res., 43, 1115, 10.1021/ar100023y

Lee, 2009, Metal-organic framework materials as catalysts, Chem. Soc. Rev., 38, 1450, 10.1039/b807080f

Kuo, 2012, Yolk-shell Nanocrystal@ZIF-8 nanostructures for gas-phase heterogeneous catalysis with selectivity control, J. Am. Chem. Soc., 134, 14345, 10.1021/ja306869j

Ockwig, 2005, Reticular chemistry: occurrence and taxonomy of nets and grammar for the design of frameworks, Acc. Chem. Res., 38, 176, 10.1021/ar020022l

Eddaoudi, 2001, Modular chemistry: secondary building units as a basis for the design of highly porous and robust metal-organic carboxylate frameworks, Acc. Chem. Res., 34, 319, 10.1021/ar000034b

Taylor, 2008, Manganese-based nanoscale metal organic frameworks for magnetic resonance imaging, J. Am. Chem. Soc., 130, 14358, 10.1021/ja803777x

Gao, 2017, Controllable synthesis of a smart multifunctional nanoscale metal–organic framework for magnetic resonance/optical imaging and targeted drug delivery, ACS Appl. Mater. Interfaces, 9, 3455, 10.1021/acsami.6b14795

Liu, 2017, Multifunctional metal–organic framework nanoprobe for cathepsin B-Activated cancer cell imaging and chemo-photodynamic therapy, ACS Appl. Mater. Interfaces, 9, 2150, 10.1021/acsami.6b14446

Liédana, 2012, CAF@ZIF-8: one-step encapsulation of caffeine in MOF, ACS Appl. Mater. Interfaces, 4, 5016, 10.1021/am301365h

Imaz, 2010, Coordination polymer particles as potential drug delivery systems, Chem. Commun., 46, 4737, 10.1039/c003084h

Rojas, 2016, Nanoscaled zinc pyrazolate metal–organic frameworks as drug-delivery systems, Inorg. Chem., 55, 2650, 10.1021/acs.inorgchem.6b00045

Zhang, 2017, Rational design of metal organic framework nanocarrier-based codelivery system of Doxorubicin hydrochloride/verapamil hydrochloride for overcoming multidrug resistance with efficient targeted cancer therapy, ACS Appl. Mater. Interfaces, 9, 19687, 10.1021/acsami.7b05142

Keskin, 2011, Biomedical applications of metal organic frameworks, Ind. Eng. Chem. Res., 50, 1799, 10.1021/ie101312k

Hinks, 2010, Metal organic frameworks as no delivery materials for biological applications, Microporous Mesoporous Mater., 129, 330, 10.1016/j.micromeso.2009.04.031

Horcajada, 2010, Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging, Nat. Mater., 9, 172, 10.1038/nmat2608

Babarao, 2009, Unraveling the energetics and dynamics of ibuprofen in mesoporous metal-organic frameworks, J. Phys. Chem. C, 113, 18287, 10.1021/jp906429s

Hunt, 2008, Room temperature synthesis of metal-organic frameworks: MOF-5, MOF-74, MOF-177, MOF-199, and IRMOF0, Tetrahedron, 64, 8553, 10.1016/j.tet.2008.06.036

Adhikari, 2016, A smart approach for in situ one step encapsulation and controlled delivery of chemotherapeutic drug using metal organic framework-drug composite in aqueous medium, ChemPhysChem, 17, 1070, 10.1002/cphc.201501012

Li, 1999, Design and synthesis of an exceptionally stable and highly porous metal-organic framework, Nature, 402, 276, 10.1038/46248

Carvalho, 2009, Dox: the good, the bad and the ugly effect, Curr. Med. Chem., 16, 3267, 10.2174/092986709788803312

Zhang, 2006, How to stabilize phospholipid liposomes (using nanoparticles), Nano Lett., 6, 694, 10.1021/nl052455y

Li, 2010, Stimulus-responsive polymeric nanoparticles for biomedical applications, Sci. China Chem., 53, 447, 10.1007/s11426-010-0101-4

Rajput, 2010, Stomach-specific mucoadhesive microsphere as a controlled drug delivery system, Sys. Rev. Pharm., 1, 70, 10.4103/0975-8453.59515

Read, 1998, Gastrointestinal dynamics and pharmacology for the optimum design of controlled-release oral dosage forms, Crit. Rev. Ther. Drug Carrier Syst., 4, 221

Kararli, 1995, Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals, Biopharm Drug Dispos., 16, 351, 10.1002/bdd.2510160502

Shen, 2011, Mesoporous silica nanoparticles loading Dox reverse multidrug resistance: performance and mechanism, Nanoscale, 3, 4314, 10.1039/c1nr10580a

Thakur, 2012, Photophysical and photodynamical study of ellipticine: an anticancer drug molecule in bile salt modulated in vitro created liposome, Phys. Chem. Chem. Phys., 14, 15369, 10.1039/c2cp41708a

Adhikari, 2015, A. Chakraborty controlled release of a sparingly water-soluble anticancer drug through pH-responsive functionalized gold-nanoparticle-decorated liposomes, ChemPhysChem, 16, 866, 10.1002/cphc.201402748

Tong, 2013, Influence of framework metal ions on the dye capture behavior of MIL-100 (Fe, Cr) MOF type solids, J. Mater. Chem. A, 1, 8534, 10.1039/c3ta11807j

Huang, 2014, Zn-BTC MOFs with active metal sites synthesized via a structure-directing approach for highly efficient carbon conversion, Chem. Commun., 50, 2624, 10.1039/C3CC49187K

Meng, 2010, Engineered design of mesoporous silica nanoparticles to deliver dox and P-Glycoprotein siRNA to overcome drug resistance in a cancer cell line, ACS Nano, 4, 4539, 10.1021/nn100690m

Vivero-Escoto, 2010, Mesoporous silica nanoparticles for intracellular controlled drug delivery, Small, 6, 1952, 10.1002/smll.200901789

Tang, 2012, Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery, Adv. Mater., 24, 1504, 10.1002/adma.201104763

Fang, 2012, Photo- and pH-triggered release of anticancer drugs from mesoporous silica-coated Pd@Ag nanoparticles, Adv. Funct. Mater., 22, 842, 10.1002/adfm.201101960

Anand, 2014, Host–guest interactions in Fe(III)-Trimesate MOF nanoparticles loaded with dox, J. Phys. Chem. B, 118, 8532, 10.1021/jp503809w

Horcajada, 2010, Porous metal–organic-framework nanoscale carriers as a potential platform for drug delivery and imaging, Nat. Mater., 9, 172, 10.1038/nmat2608

Das, 2016, First evidence of the liposome-mediated deintercalation of anticancer drug Doxorubicin from the drug-DNA complex: a spectroscopic approach, Langmuir, 32, 159, 10.1021/acs.langmuir.5b03702

Das, 2016, Lipoplex mediated de-intercalation of Doxorubicin from calf thymus DNA-doxorubicin complex, Langmuir, 32, 8889, 10.1021/acs.langmuir.6b01860

di Nunzio, 2013, A “ship in a bottle” strategy to load a hydrophilic anticancer drug in porous metal organic framework nanoparticles: efficient encapsulation, matrix stabilization, and photodelivery, J. Med. Chem., 57, 411, 10.1021/jm4017202

Li, 2012, Mesoporous silica nanoparticles in biomedical applications, Chem. Soc. Rev., 41, 2590, 10.1039/c1cs15246g

Songa, 2015, Molecular and supramolecular switches on mesoporous silica nanoparticles, Chem. Soc. Rev., 44, 3474, 10.1039/C5CS00243E

Turco, 1995, A simple model based on first order kinetics to explain release of highly water-soluble drugs from porous dicalcium phosphate dihydrate matrices, Drug Dev. Ind. Pharm., 21, 943, 10.3109/03639049509026658

Joseph, 1968, Drug release from wax matrices Analysis of data with first-order kinetics and with the diffusion-controlled model, J. Pharm. Sci., 57, 274, 10.1002/jps.2600570206